The company

Cumulus (previously BrainWaveBank) is developing faster, more effective tools to help its partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. It has created a next-generation integrated physiological and digital biomarker platform. The platform captures large amounts of real-world lab quality data through time, across five critical behavioural and mechanistic domains by tracking physiology, functions, and symptoms in clinics and the patient’s home. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.